Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NTP-TERAZOSIN 10 MG

TERAZOSIN (TERAZOSIN HYDROCHLORIDE) : 10 MG · DIN 02346761 · TEVA CANADA LIMITED

Health Canada status: CANCELLED PRE MARKET

What is NTP-TERAZOSIN?

NTP-TERAZOSIN 10 MG contains TERAZOSIN (TERAZOSIN HYDROCHLORIDE) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02346761, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 06-Aug-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is NTP-TERAZOSIN used for?

NTP-TERAZOSIN (terazosin hydrochloride) is indicated in the treatment of mild to moderate hypertension. It is employed in a general treatment program in conjunction with a thiazide diuretic and/or other antihypertensive drugs as needed for sufficient patient response. NTP-TERAZOSIN can be tried as a sole therapy in those patients in whom other agents caused adverse effects or are inappropriate. NTP-TERAZOSIN (terazosin hydrochloride) is also indicated for the treatment of symptoms of benign prostatic hyperplasia (BPH).

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02346761
Brand nameNTP-TERAZOSIN
Generic / active ingredientTERAZOSIN (TERAZOSIN HYDROCHLORIDE) : 10 MG
ManufacturerTEVA CANADA LIMITED
Strength10 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeG04CA03 TERAZOSIN
AHFS class24:20.00
BiosimilarNo
Health Canada statusCANCELLED PRE MARKET
Status date06-Aug-2015

How is it stored and handled?

Store between 15 - 30°C and protect from light and high humidity. Store unit dose boxes between 15 - 25°C and protect from light and high humidity.

How is it supplied?

All strengths are available in bottles of 100.

What can be used instead?

Other Canadian products sharing ATC code G04CA03 TERAZOSIN. 8 of 57 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-TERAZOSIN1 MGTABLETAPOTEX INCMARKETEDDIN 02234502
APO-TERAZOSIN10 MGTABLETAPOTEX INCMARKETEDDIN 02234505
APO-TERAZOSIN2 MGTABLETAPOTEX INCMARKETEDDIN 02234503
APO-TERAZOSIN5 MGTABLETAPOTEX INCMARKETEDDIN 02234504
PMS-TERAZOSIN1 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02243518
PMS-TERAZOSIN10 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02243521
PMS-TERAZOSIN2 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02243519
PMS-TERAZOSIN5 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02243520
DOM-TERAZOSIN1 MGTABLETDOMINION PHARMACALCANCELLED POST MARKETDIN 02243746
DOM-TERAZOSIN10 MGTABLETDOMINION PHARMACALCANCELLED POST MARKETDIN 02243749

Who else supplies TERAZOSIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. TERAZOSIN appears in 14 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for NTP-TERAZOSIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for NTP-TERAZOSIN

Health Canada Drug Product Database (DPD), DIN 02346761. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.